He
Helsinn
Lugano CHFounded 1976900 employees
Private CappharmaPrivateOncologyGI
Platform: Supportive Care
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisosertib | HEL-1482 | Phase 1 | 1 | BTK | NSCLC | ||
| Darasertib | HEL-9266 | Phase 1/2 | 2 | PI3Kα | SCDAtopic Derm |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)